Bliss GVS Pharma, 506197, BLISSGVS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

759.27
10.73
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

686.70
0.69%
0.86

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.54
-1.71
2.74

EBITDA CAGR (%)

10 Years
5 Years
3 Years

0.63
-9.70
-0.82

PAT CAGR (%)

10 Years
5 Years
3 Years

-12.58
-23.86
-46.33

P:E (Median)

8 Years
5 Years
3 Years

19.26
17.32
19.67

P:BV (Average)

8 Years
5 Years
3 Years

2.52
1.78
1.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.58
7.73
7.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 143.42 138.30 3.70% 168.79 190.60 -11.44% 138.85 174.43 -20.40% 147.28 133.03 10.71%
Expenses 132.51 119.62 10.78% 135.33 158.77 -14.76% 112.21 141.66 -20.79% 128.13 107.10 19.64%
EBITDA 10.91 18.68 -41.60% 33.46 31.82 5.15% 26.64 32.76 -18.68% 19.15 25.93 -26.15%
EBIDTM 7.61% 13.51% 19.82% 16.70% 19.18% 18.78% 13.00% 19.49%
Other Income 6.48 12.44 -47.91% 11.42 6.31 80.98% 14.23 5.99 137.56% 18.63 7.90 135.82%
Interest 4.97 1.54 222.73% 1.20 0.95 26.32% 1.84 0.53 247.17% 2.04 1.30 56.92%
Depreciation 3.97 3.41 16.42% 3.79 3.51 7.98% 3.74 3.45 8.41% 3.67 3.48 5.46%
PBT 8.44 26.17 -67.75% 39.89 36.41 9.56% 35.29 34.77 1.50% 32.06 29.04 10.40%
Tax 2.34 7.07 -66.90% 10.61 9.24 14.83% 9.85 10.04 -1.89% 7.42 7.39 0.41%
PAT 6.11 19.10 -68.01% 29.28 27.17 7.77% 25.45 24.73 2.91% 24.64 21.66 13.76%
PATM 4.26% 13.81% 17.35% 14.26% 18.33% 14.18% 16.73% 16.28%
EPS 0.59 1.83 -67.76% 2.81 2.61 7.66% 2.44 2.37 2.95% 2.37 2.08 13.94%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 184.78 167.06 10.61% 205.72 216.26 -4.87% 172.43 195.99 -12.02% 188.66 168.15 12.20%
Expenses 178.54 146.90 21.54% 158.03 182.09 -13.21% 147.88 166.58 -11.23% 149.81 133.54 12.18%
EBITDA 6.24 20.17 -69.06% 47.69 34.16 39.61% 24.55 29.41 -16.52% 38.85 34.60 12.28%
EBIDTM 3.38% 12.07% 23.18% 15.80% 14.23% 15.00% 20.59% 20.58%
Other Income 2.98 12.19 -75.55% 5.65 6.04 -6.46% 2.15 5.45 -60.55% 7.01 7.82 -10.36%
Interest 5.08 1.63 211.66% 1.26 1.04 21.15% 1.91 0.68 180.88% 2.11 1.40 50.71%
Depreciation 4.88 4.27 14.29% 4.64 4.43 4.74% 4.60 4.30 6.98% 4.55 4.33 5.08%
PBT -0.75 26.45 - 47.43 -38.86 - 20.19 29.89 -32.45% 39.20 36.69 6.84%
Tax -4.22 2.99 - 17.64 9.67 82.42% 4.19 7.83 -46.49% 11.72 10.55 11.09%
PAT 3.47 23.47 -85.22% 29.79 -48.53 - 16.00 22.06 -27.47% 27.48 26.13 5.17%
PATM 1.88% 14.05% 14.48% -22.44% 9.28% 11.25% 14.56% 15.54%
EPS 0.32 1.89 -83.07% 2.68 -4.83 - 1.33 2.05 -35.12% 2.48 2.35 5.53%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 598.34 636.36 465.51 441.95 426.59 297.89 348.02 326.38 313.02 288.23 353.68 Net Sales Growth -5.97% 36.70% 5.33% 3.60% 43.20% -14.40% 6.63% 4.27% 8.60% -18.51% Cost Of Goods Sold 314.90 343.94 253.30 236.73 225.15 145.81 167.21 114.36 116.45 127.84 163.89 Gross Profit 283.44 292.41 212.21 205.23 201.44 152.08 180.80 212.03 196.57 160.40 189.79 GP Margin 47.37% 45.95% 45.59% 46.44% 47.22% 51.05% 51.95% 64.96% 62.80% 55.65% 53.66% Total Expenditure 508.18 527.16 374.05 341.78 333.49 209.43 247.49 229.87 226.83 222.16 252.90 Power & Fuel Cost - 7.09 6.99 4.70 3.57 2.59 2.73 2.82 2.69 1.80 1.45 % Of Sales - 1.11% 1.50% 1.06% 0.84% 0.87% 0.78% 0.86% 0.86% 0.62% 0.41% Employee Cost - 65.06 58.61 44.02 33.85 26.29 25.03 21.89 17.36 12.93 9.87 % Of Sales - 10.22% 12.59% 9.96% 7.94% 8.83% 7.19% 6.71% 5.55% 4.49% 2.79% Manufacturing Exp. - 10.91 7.13 5.97 4.24 3.64 3.31 23.87 27.77 20.26 24.04 % Of Sales - 1.71% 1.53% 1.35% 0.99% 1.22% 0.95% 7.31% 8.87% 7.03% 6.80% General & Admin Exp. - 12.00 8.70 10.33 13.71 11.11 11.73 17.31 18.20 10.21 10.52 % Of Sales - 1.89% 1.87% 2.34% 3.21% 3.73% 3.37% 5.30% 5.81% 3.54% 2.97% Selling & Distn. Exp. - 55.70 28.56 26.16 31.07 14.77 26.29 35.26 31.20 33.56 39.23 % Of Sales - 8.75% 6.14% 5.92% 7.28% 4.96% 7.55% 10.80% 9.97% 11.64% 11.09% Miscellaneous Exp. - 32.45 10.76 13.88 21.91 5.22 11.18 14.35 13.16 15.57 39.23 % Of Sales - 5.10% 2.31% 3.14% 5.14% 1.75% 3.21% 4.40% 4.20% 5.40% 1.10% EBITDA 90.16 109.20 91.46 100.17 93.10 88.46 100.53 96.51 86.19 66.07 100.78 EBITDA Margin 15.07% 17.16% 19.65% 22.67% 21.82% 29.70% 28.89% 29.57% 27.53% 22.92% 28.49% Other Income 50.76 32.63 19.41 37.00 35.81 10.99 9.08 23.08 21.35 30.12 15.03 Interest 10.05 4.32 5.92 6.62 3.15 6.95 9.07 13.53 11.21 9.44 6.55 Depreciation 15.17 13.85 13.76 8.83 5.75 5.67 5.62 5.85 5.08 4.46 4.43 PBT 115.68 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 82.30 104.83 Tax 30.22 33.74 23.69 29.38 45.58 29.82 35.77 34.60 31.24 28.37 48.15 Tax Rate 26.12% 26.69% 25.98% 24.14% 37.98% 34.34% 37.69% 34.53% 34.24% 34.47% 45.93% PAT 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 53.93 56.68 PAT before Minority Interest 85.48 92.66 67.50 92.33 74.43 57.01 59.13 65.61 60.02 53.93 56.68 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.29% 14.56% 14.50% 20.89% 17.45% 19.14% 16.99% 20.10% 19.17% 18.71% 16.03% PAT Growth -7.75% 37.27% -26.89% 24.05% 30.56% -3.59% -9.88% 9.31% 11.29% -4.85% EPS 8.20 8.89 6.48 8.86 7.14 5.47 5.67 6.30 5.76 5.18 5.44

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 751.59 747.45 577.21 689.31 898.57 814.64 798.44 546.89 407.13 344.64 396.63 Net Sales Growth 0.55% 29.49% -16.26% -23.29% 10.30% 2.03% 46.00% 34.33% 18.13% -13.11% Cost Of Goods Sold 401.33 390.98 329.71 439.97 612.26 391.13 358.93 237.18 152.77 132.01 167.90 Gross Profit 350.26 356.47 247.49 249.34 286.31 423.52 439.51 309.72 254.37 212.63 228.72 GP Margin 46.60% 47.69% 42.88% 36.17% 31.86% 51.99% 55.05% 56.63% 62.48% 61.70% 57.67% Total Expenditure 634.26 629.11 470.56 565.99 740.93 617.50 595.70 391.17 303.70 273.42 285.47 Power & Fuel Cost - 8.25 8.14 5.88 4.76 5.49 5.58 4.72 4.36 2.93 2.18 % Of Sales - 1.10% 1.41% 0.85% 0.53% 0.67% 0.70% 0.86% 1.07% 0.85% 0.55% Employee Cost - 76.15 68.09 53.69 42.32 69.23 61.35 33.74 29.43 23.46 15.08 % Of Sales - 10.19% 11.80% 7.79% 4.71% 8.50% 7.68% 6.17% 7.23% 6.81% 3.80% Manufacturing Exp. - 12.09 7.83 7.07 4.95 4.88 5.39 25.65 29.98 41.44 37.17 % Of Sales - 1.62% 1.36% 1.03% 0.55% 0.60% 0.68% 4.69% 7.36% 12.02% 9.37% General & Admin Exp. - 15.22 12.03 13.27 17.05 39.48 36.36 24.68 17.07 15.16 14.63 % Of Sales - 2.04% 2.08% 1.93% 1.90% 4.85% 4.55% 4.51% 4.19% 4.40% 3.69% Selling & Distn. Exp. - 66.56 31.35 28.83 34.72 62.09 92.46 42.51 47.05 35.12 40.26 % Of Sales - 8.90% 5.43% 4.18% 3.86% 7.62% 11.58% 7.77% 11.56% 10.19% 10.15% Miscellaneous Exp. - 59.86 13.40 17.28 24.86 45.21 35.63 22.71 23.03 23.30 40.26 % Of Sales - 8.01% 2.32% 2.51% 2.77% 5.55% 4.46% 4.15% 5.66% 6.76% 2.08% EBITDA 117.33 118.34 106.65 123.32 157.64 197.14 202.74 155.72 103.43 71.22 111.16 EBITDA Margin 15.61% 15.83% 18.48% 17.89% 17.54% 24.20% 25.39% 28.47% 25.40% 20.67% 28.03% Other Income 17.79 31.49 21.95 39.19 37.63 26.54 12.51 24.35 20.29 28.00 14.07 Interest 10.36 4.74 7.24 7.57 4.41 22.80 19.69 18.61 16.41 17.98 9.72 Depreciation 18.67 17.33 17.23 12.59 8.94 21.38 20.14 13.26 11.30 10.68 6.03 PBT 106.07 127.76 104.13 142.35 181.92 179.49 175.40 148.19 96.02 70.56 109.48 Tax 29.33 31.04 30.16 33.71 55.25 56.63 62.72 48.05 34.63 29.53 49.90 Tax Rate 27.65% 57.30% 28.96% 26.14% 30.37% 38.98% 35.76% 32.42% 36.07% 41.85% 45.58% PAT 76.74 15.04 68.49 97.26 123.72 58.78 82.04 82.49 59.91 40.99 57.72 PAT before Minority Interest 70.86 23.13 73.97 95.25 126.66 88.66 112.68 100.15 61.39 41.03 59.58 Minority Interest -5.88 -8.09 -5.48 2.01 -2.94 -29.88 -30.64 -17.66 -1.48 -0.04 -1.86 PAT Margin 10.21% 2.01% 11.87% 14.11% 13.77% 7.22% 10.28% 15.08% 14.72% 11.89% 14.55% PAT Growth 231.78% -78.04% -29.58% -21.39% 110.48% -28.35% -0.55% 37.69% 46.16% -28.98% EPS 7.36 1.44 6.57 9.33 11.87 5.64 7.87 7.92 5.75 3.93 5.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 851.43 755.65 682.94 603.27 541.42 491.64 432.07 368.19 314.84 258.74 Share Capital 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 831.12 735.50 672.63 592.96 531.11 481.33 421.76 357.87 304.53 248.42 Non-Current Liabilities 35.71 43.87 46.66 40.60 15.73 22.84 21.78 38.76 52.44 58.78 Secured Loans 23.22 32.49 35.55 30.53 5.55 12.47 11.84 30.21 45.14 53.68 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.07 2.50 2.44 1.75 1.91 1.81 1.67 1.40 1.10 0.74 Current Liabilities 192.83 146.11 125.50 91.98 136.85 151.82 243.28 148.05 236.68 138.67 Trade Payables 84.21 66.78 55.95 30.87 35.34 63.80 35.06 50.47 58.99 92.43 Other Current Liabilities 62.46 42.36 32.75 23.47 11.81 11.84 29.10 39.13 28.52 13.82 Short Term Borrowings 41.47 35.38 35.94 36.64 82.53 61.50 49.95 28.38 23.14 18.21 Short Term Provisions 4.69 1.59 0.87 1.01 7.18 14.68 129.17 30.08 126.04 14.22 Total Liabilities 1,079.97 945.63 855.10 735.85 694.00 666.30 697.13 555.00 603.96 456.19 Net Block 224.31 174.10 178.86 78.32 72.48 75.34 79.09 81.50 53.53 48.79 Gross Block 269.54 210.93 202.33 93.44 83.40 80.85 122.93 119.59 86.50 77.30 Accumulated Depreciation 45.22 36.84 23.47 15.12 10.92 5.51 43.84 38.08 32.97 28.51 Non Current Assets 289.05 268.98 212.46 157.95 117.72 111.50 212.12 202.08 186.24 163.83 Capital Work in Progress 22.15 2.39 0.00 42.91 0.47 1.98 1.98 0.00 4.31 0.65 Non Current Investment 18.94 18.99 19.00 19.01 19.17 21.54 20.59 19.23 19.23 19.22 Long Term Loans & Adv. 23.27 11.35 13.36 17.38 25.31 12.23 110.45 101.35 109.18 95.17 Other Non Current Assets 0.37 62.15 1.24 0.33 0.29 0.42 0.00 0.00 0.00 0.00 Current Assets 790.92 676.64 642.65 577.90 576.29 554.80 485.02 352.49 416.30 289.94 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 90.11 83.68 60.57 54.84 39.80 28.06 21.95 22.52 21.23 24.58 Sundry Debtors 408.82 348.68 404.91 342.09 282.54 239.41 250.58 210.61 183.53 218.21 Cash & Bank 149.48 119.52 86.62 93.29 70.29 83.57 56.90 47.37 74.12 30.82 Other Current Assets 142.49 23.28 16.30 25.28 183.65 203.76 155.59 71.99 137.41 16.33 Short Term Loans & Adv. 125.72 101.48 74.25 62.40 143.27 173.39 136.36 50.95 124.55 5.13 Net Current Assets 598.09 530.54 517.15 485.92 439.44 402.98 241.74 204.43 179.61 151.27 Total Assets 1,079.97 945.62 855.11 735.85 694.01 666.30 697.14 555.00 603.96 456.18

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 818.70 808.25 735.61 646.00 536.24 486.62 412.62 337.08 286.88 258.01 Share Capital 10.37 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 798.40 788.10 725.30 635.68 525.92 476.31 402.31 326.77 276.57 247.69 Non-Current Liabilities 29.20 45.24 46.32 37.99 12.92 32.81 49.55 67.52 95.65 96.92 Secured Loans 23.22 32.60 37.24 32.54 5.92 25.58 29.62 55.03 78.80 89.97 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 8.62 2.23 8.79 1.33 Long Term Provisions 1.07 2.50 2.44 1.75 1.91 2.05 1.81 1.40 1.10 0.74 Current Liabilities 233.09 203.64 230.53 207.03 299.40 437.09 378.97 242.68 307.66 202.19 Trade Payables 92.61 74.22 89.92 78.88 58.43 98.25 108.49 80.33 82.35 118.15 Other Current Liabilities 67.85 53.69 57.21 50.24 124.46 99.93 52.76 70.30 42.12 24.45 Short Term Borrowings 60.70 65.04 66.39 64.30 105.66 187.47 62.12 61.04 57.05 45.16 Short Term Provisions 11.93 10.69 17.01 13.61 10.85 51.45 155.60 31.00 126.14 14.44 Total Liabilities 1,108.75 1,076.79 1,027.22 904.88 860.04 1,022.90 874.24 662.17 700.35 570.92 Net Block 280.76 233.72 240.97 144.97 136.48 303.86 225.25 234.38 213.31 168.23 Gross Block 343.41 285.10 276.07 169.89 157.47 326.83 300.74 293.82 262.45 205.92 Accumulated Depreciation 62.65 51.38 35.10 24.92 20.99 22.97 75.48 59.44 49.14 37.69 Non Current Assets 332.71 311.59 257.48 211.39 170.25 456.97 291.23 244.66 229.67 219.61 Capital Work in Progress 22.15 2.39 0.00 46.74 0.47 4.03 9.10 0.00 4.33 0.65 Non Current Investment 3.08 0.70 0.72 0.72 6.30 1.05 0.11 0.01 0.01 0.01 Long Term Loans & Adv. 25.25 12.63 14.56 18.63 26.72 11.45 56.77 10.27 12.02 50.72 Other Non Current Assets 1.47 62.15 1.24 0.33 0.29 136.58 0.00 0.00 0.00 0.00 Current Assets 776.03 765.20 769.74 693.49 689.79 565.93 583.00 417.08 469.26 348.89 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 123.94 98.93 74.14 77.37 59.03 49.30 38.67 33.70 32.53 32.52 Sundry Debtors 392.75 463.82 547.91 460.73 298.48 254.45 300.93 247.47 215.03 244.64 Cash & Bank 177.53 144.55 103.32 106.63 88.86 150.50 78.18 57.29 80.37 50.35 Other Current Assets 81.82 17.55 16.13 26.21 243.41 111.68 165.22 78.62 141.34 21.37 Short Term Loans & Adv. 67.70 40.35 28.24 22.55 146.30 78.44 149.92 60.69 130.30 8.92 Net Current Assets 542.95 561.56 539.21 486.47 390.39 128.84 204.03 174.40 161.60 146.70 Total Assets 1,108.74 1,076.79 1,027.22 904.88 860.04 1,022.90 874.23 662.17 700.35 570.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 114.05 66.97 63.22 48.29 22.67 38.48 59.61 15.35 64.71 -51.86 PBT 123.66 91.19 121.71 120.01 86.84 94.91 100.21 91.25 82.30 104.83 Adjustment 35.10 41.14 3.43 3.36 0.77 28.12 7.21 14.91 6.89 5.09 Changes in Working Capital -14.23 -42.64 -30.07 -25.53 -29.06 -47.37 -27.78 -50.62 8.78 -123.38 Cash after chg. in Working capital 144.52 89.69 95.08 97.84 58.54 75.65 79.64 55.55 97.97 -13.45 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -30.47 -22.72 -31.86 -49.55 -35.87 -37.17 -20.03 -40.19 -33.26 -38.41 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -92.28 -61.62 -60.14 -68.04 16.36 -29.34 -10.29 -21.49 -24.00 -26.80 Net Fixed Assets -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 -12.91 Net Investments 0.05 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 -18.19 Others -13.96 -50.64 5.83 -15.72 15.03 -70.47 -3.61 7.29 -11.13 4.30 Cash from Financing Activity -12.62 -11.67 -5.83 9.05 -21.91 -14.77 -35.34 -31.23 -49.97 51.56 Net Cash Inflow / Outflow 9.14 -6.33 -2.75 -10.70 17.12 -5.63 13.98 -37.37 -9.26 -27.09 Opening Cash & Equivalents 4.67 11.00 13.75 24.45 7.33 12.95 3.40 38.70 52.58 57.90 Closing Cash & Equivalent 13.82 4.67 11.00 13.75 24.45 7.33 12.95 3.40 43.32 30.82

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 135.48 63.97 46.70 39.95 17.64 289.47 112.95 48.94 41.15 6.50 PBT 127.76 104.13 128.97 181.91 179.49 175.40 148.19 96.02 70.56 109.48 Adjustment -31.71 46.29 26.85 -10.97 17.55 36.24 18.18 22.48 24.11 9.71 Changes in Working Capital 73.37 -57.89 -70.32 -183.07 -140.80 113.48 -8.33 -60.94 -19.30 -73.94 Cash after chg. in Working capital 169.42 92.53 85.49 -12.13 56.24 325.13 158.05 57.56 75.36 45.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -33.94 -28.56 -38.79 52.08 -38.61 -35.66 -45.10 -8.63 -34.21 -38.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -92.98 -46.99 -47.89 -73.52 50.24 -231.25 -49.84 -38.98 -10.90 -124.05 Net Fixed Assets -78.37 -10.99 -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 -12.91 Net Investments 0.05 0.01 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 -18.19 Others -14.66 -36.01 18.08 -21.20 48.91 -272.38 -43.16 -10.20 1.97 -92.95 Cash from Financing Activity -23.73 -20.80 -6.30 16.83 -75.98 -10.13 -40.25 -43.26 -8.47 109.89 Net Cash Inflow / Outflow 18.78 -3.82 -7.50 -16.74 -8.10 48.09 22.85 -33.31 21.77 -7.66 Opening Cash & Equivalents 13.13 15.34 15.04 36.95 47.41 0.00 5.09 49.57 27.79 58.01 Closing Cash & Equivalent 21.99 13.13 15.34 15.04 36.95 47.41 27.60 16.26 49.57 50.35

Financial Ratios

Consolidated /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 81.16 72.31 66.21 58.49 52.49 47.66 41.89 35.65 30.39 24.85 ROA 9.15% 7.50% 11.61% 10.41% 8.38% 8.67% 10.48% 10.36% 10.17% 15.60% ROE 11.68% 9.45% 14.36% 13.00% 11.04% 12.80% 16.41% 17.62% 18.93% 24.29% ROCE 14.68% 12.02% 17.75% 18.80% 15.60% 19.25% 23.43% 23.91% 25.07% 40.59% Fixed Asset Turnover 2.65 2.25 2.99 4.82 3.63 3.44 2.70 3.06 3.53 5.00 Receivable days 217.24 295.44 308.46 267.22 319.34 255.29 257.00 228.48 253.33 178.64 Inventory Days 49.84 56.55 47.66 40.49 41.51 26.05 24.78 25.36 28.89 19.20 Payable days 80.11 88.42 48.84 39.16 90.96 75.73 75.81 99.92 138.16 97.63 Cash Conversion Cycle 186.97 263.57 307.29 268.56 269.89 205.62 205.97 153.91 144.06 100.20 Total Debt/Equity 0.10 0.12 0.13 0.12 0.17 0.15 0.19 0.24 0.28 0.30 Interest Cover 30.23 16.40 19.38 39.08 13.49 11.46 8.41 9.14 9.72 16.99

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 78.01 77.41 71.32 62.63 51.99 47.18 40.00 32.64 27.67 24.78 ROA 2.12% 7.03% 9.86% 14.35% 9.42% 11.88% 13.04% 9.01% 6.46% 13.53% ROE 2.88% 9.64% 13.79% 21.43% 17.34% 25.06% 26.73% 19.74% 15.17% 25.56% ROCE 6.37% 12.49% 17.02% 26.58% 24.61% 31.06% 32.07% 23.57% 20.56% 36.18% Fixed Asset Turnover 2.38 2.06 3.09 5.49 3.37 2.56 1.85 1.47 1.48 2.95 Receivable days 209.14 319.89 267.05 154.20 123.80 126.33 182.13 206.07 241.81 171.03 Inventory Days 54.42 54.72 40.11 27.70 24.25 20.01 24.04 29.51 34.22 20.71 Payable days 77.87 90.85 56.62 35.01 51.74 67.63 95.25 108.77 148.76 105.12 Cash Conversion Cycle 185.69 283.75 250.53 146.89 96.31 78.70 110.92 126.81 127.26 86.63 Total Debt/Equity 0.13 0.15 0.16 0.16 0.22 0.46 0.32 0.47 0.60 0.58 Interest Cover 12.42 15.38 18.04 42.21 7.37 9.91 8.96 6.85 4.92 12.27

Top Investors:

arian investment limited

life insurance corporation of india

gulbarga trading and investment private

arjun gautam ashra .

gautam rasiklal ashra

investor education and protection fund authority ministry of corporate affairs

aspire emerging fund

fidelity puritan trust-fidelity low-priced stock fund

polus global fund

dishant milanbhai parikh

Annual Reports:

News Update:

USFDA conducts inspections at Bliss GVS Pharma’s manufacturing unit in Palghar
20th Mar 2023, 11:59 AM

After the inspection, the USFDA issued a Form 483 with 3 minor observations
Read More

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: